Skip to main content

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.


  • Head shot of Dr. Tim Greenamyre.

    New Findings Bolster Case for Parkinson’s Therapies Targeting LRRK2

    Recent findings suggest LRRK2 kinase inhibitors may benefit a broad array of patients.
    Learn more

  • Close up of hand holding test tube

    Second Chance for a Once-“failed” Alzheimer’s Drug

    Today, in what has been deemed a “shock move” by some media reports, aducanamab is back on the map.
    Learn more

  • Ask the PhD: Immune System’s Role in Parkinson’s Disease

    Scientists discuss how inflammation could harm cells and what researchers are doing to better define, measure, and treat this Parkinson’s pathway.
    Learn more

  • Default content image

    ASAP Initiative Launches First Funding Opportunity

    ASAP seeks to support international, multidisciplinary, multi-institutional research teams to address key knowledge gaps in the basic disease mechanisms that contribute to Parkinson’s development and…
    Learn more

  • Patients and Doctor

    The FDA Is Asking for Feedback on Medical Devices

    The FDA is asking for feedback about the patient and care partner experience with medical devices and procedures, such as deep brain stimulation (DBS).
    Learn more

  • Four beakers lined up on a table in a lab.

    New Initiative Will Engage Underrepresented Populations in Parkinson’s Research

    Four sites around the U.S. will develop community-focused programs to develop culturally relevant messaging and materials to engage the Parkinson’s community.
    Learn more

Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.